Literature DB >> 18197357

Sex differences in striatal dopaminergic function within heterozygous mutant dopamine transporter knock-out mice.

Jing Ji1, Dean E Dluzen.   

Abstract

The issue of whether a deletion of the dopamine transporter (DAT) allele (+/- DAT) would differentially alter striatal dopamine (DA) and dihydroxyphenylacetic acid (DOPAC) concentrations and DA release upon potassium and methamphetamine (MA) stimulation between male and female mice was examined. Striatal DA and DOPAC concentrations of female +/- DAT mice were significantly decreased as compared with wild type (+/+) controls and male +/- DAT mice. No such changes were obtained from the olfactory tubercle suggesting that these effects might be specific for the striatum. Potassium-stimulated DA was increased in male and female +/- DAT mice and maximally stimulated DA was obtained from +/- DAT females, although these mice showed the lowest DA concentrations. MA-evoked DA was increased in male and female +/- mice. While MA-evoked DA was significantly increased in +/+ males versus +/+ females, the +/- females showed the highest DA responses, thereby showing a reversal in the results seen in wild-type conditions. These findings indicate: (1) that a deficiency in the DAT interacts with the sex of the subject, (2)+/- DAT females show more extreme changes in dopaminergic responses, and (3) the importance for considering such variables such as sex when examining differences among knock-out conditions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18197357     DOI: 10.1007/s00702-007-0017-0

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  42 in total

1.  Sex differences in methamphetamine-evoked striatal dopamine output are abolished following gonadectomy: comparisons with potassium-evoked output and responses in prepubertal mice.

Authors:  Dean E Dluzen; Ty J Salvaterra
Journal:  Neuroendocrinology       Date:  2006-01-13       Impact factor: 4.914

2.  Influence of gonadal hormones on sexual differences in sensitivity to methamphetamine-induced neurotoxicity.

Authors:  Y L Yu; G C Wagner
Journal:  J Neural Transm Park Dis Dement Sect       Date:  1994

3.  Estrogen as a neuroprotectant against MPTP-induced neurotoxicity in C57/B1 mice.

Authors:  D E Dluzen; J L McDermott; B Liu
Journal:  Neurotoxicol Teratol       Date:  1996 Sep-Oct       Impact factor: 3.763

4.  Differential regulation of tyrosine hydroxylase in the basal ganglia of mice lacking the dopamine transporter.

Authors:  M Jaber; B Dumartin; C Sagné; J W Haycock; C Roubert; B Giros; B Bloch; M G Caron
Journal:  Eur J Neurosci       Date:  1999-10       Impact factor: 3.386

5.  Loss of autoreceptor functions in mice lacking the dopamine transporter.

Authors:  S R Jones; R R Gainetdinov; X T Hu; D C Cooper; R M Wightman; F J White; M G Caron
Journal:  Nat Neurosci       Date:  1999-07       Impact factor: 24.884

6.  Profound neuronal plasticity in response to inactivation of the dopamine transporter.

Authors:  S R Jones; R R Gainetdinov; M Jaber; B Giros; R M Wightman; M G Caron
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

7.  Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity.

Authors:  R R Gainetdinov; W C Wetsel; S R Jones; E D Levin; M Jaber; M G Caron
Journal:  Science       Date:  1999-01-15       Impact factor: 47.728

8.  Brain dopamine transporter: gender differences and effect of chronic haloperidol.

Authors:  R Rivest; P Falardeau; T Di Paolo
Journal:  Brain Res       Date:  1995-09-18       Impact factor: 3.252

9.  Anterior pituitary hypoplasia and dwarfism in mice lacking the dopamine transporter.

Authors:  R Bossé; F Fumagalli; M Jaber; B Giros; R R Gainetdinov; W C Wetsel; C Missale; M G Caron
Journal:  Neuron       Date:  1997-07       Impact factor: 17.173

10.  The impact of gender and estrogen on striatal dopaminergic neurotoxicity.

Authors:  D B Miller; S F Ali; J P O'Callaghan; S C Laws
Journal:  Ann N Y Acad Sci       Date:  1998-05-30       Impact factor: 5.691

View more
  12 in total

1.  Heightened Dopaminergic Response to Amphetamine at the D3 Dopamine Receptor in Methamphetamine Users.

Authors:  Isabelle Boileau; Doris Payer; Pablo M Rusjan; Sylvain Houle; Junchao Tong; Tina McCluskey; Alan A Wilson; Stephen J Kish
Journal:  Neuropsychopharmacology       Date:  2016-06-29       Impact factor: 7.853

Review 2.  Estrogen actions in the brain and the basis for differential action in men and women: a case for sex-specific medicines.

Authors:  Glenda E Gillies; Simon McArthur
Journal:  Pharmacol Rev       Date:  2010-04-14       Impact factor: 25.468

3.  Subchronic nandrolone administration reduces cocaine-induced dopamine and 5-hydroxytryptamine outflow in the rat nucleus accumbens.

Authors:  Sanna Kurling-Kailanto; Aino Kankaanpää; Timo Seppälä
Journal:  Psychopharmacology (Berl)       Date:  2010-02-26       Impact factor: 4.530

4.  Developmental vitamin D deficiency alters dopamine-mediated behaviors and dopamine transporter function in adult female rats.

Authors:  James P Kesby; Xiaoying Cui; Jonathan O'Loan; John J McGrath; Thomas H J Burne; Darryl W Eyles
Journal:  Psychopharmacology (Berl)       Date:  2009-11-18       Impact factor: 4.530

5.  Multisite, randomized, double-blind, placebo-controlled pilot clinical trial to evaluate the efficacy of buspirone as a relapse-prevention treatment for cocaine dependence.

Authors:  Theresa M Winhusen; Frankie Kropp; Robert Lindblad; Antoine Douaihy; Louise Haynes; Candace Hodgkins; Karen Chartier; Kyle M Kampman; Gaurav Sharma; Daniel F Lewis; Paul VanVeldhuisen; Jeff Theobald; Jeanine May; Gregory S Brigham
Journal:  J Clin Psychiatry       Date:  2014-07       Impact factor: 4.384

6.  The human testis-determining factor SRY localizes in midbrain dopamine neurons and regulates multiple components of catecholamine synthesis and metabolism.

Authors:  Daniel P Czech; Joohyung Lee; Helena Sim; Clare L Parish; Eric Vilain; Vincent R Harley
Journal:  J Neurochem       Date:  2012-06-08       Impact factor: 5.372

Review 7.  Sex differences in dopamine release regulation in the striatum.

Authors:  Jennifer E Zachry; Suzanne O Nolan; Lillian J Brady; Shannon J Kelly; Cody A Siciliano; Erin S Calipari
Journal:  Neuropsychopharmacology       Date:  2020-12-14       Impact factor: 7.853

8.  Markers associated with sex differences in methamphetamine-induced striatal dopamine neurotoxicity.

Authors:  D E Dluzen; J L McDermott; M Bourque; T Di Paolo; A S Darvesh; A B Buletko; N J Laping
Journal:  Curr Neuropharmacol       Date:  2011-03       Impact factor: 7.363

9.  Mesocorticolimbic monoamine correlates of methamphetamine sensitization and motivation.

Authors:  Kevin D Lominac; Courtney L McKenna; Lisa M Schwartz; Paige N Ruiz; Melissa G Wroten; Bailey W Miller; John J Holloway; Katherine O Travis; Ganesh Rajasekar; Dan Maliniak; Andrew B Thompson; Lawrence E Urman; Tamara J Phillips; Karen K Szumlinski
Journal:  Front Syst Neurosci       Date:  2014-05-07

Review 10.  Sex differences in Parkinson's disease.

Authors:  Glenda E Gillies; Ilse S Pienaar; Shiv Vohra; Zahi Qamhawi
Journal:  Front Neuroendocrinol       Date:  2014-03-04       Impact factor: 8.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.